ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Orthopaedic Surgery

Top Orthopaedic Surgery Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANTHONY DIGIOIA MD

Orthopaedic Surgery

1,570

$50.2K

546
507 are 65+

5%
patients receiving schedule two controlled substances

Avg: 23%

39%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 10%

$32
Average prescription price

Avg: $40

THOMAS CORCORAN M.D.

Orthopaedic Surgery

1,426

$34.6K

522
389 are 65+

4%
patients receiving schedule two controlled substances

Avg: 23%

23%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 10%

$24
Average prescription price

Avg: $40

SCOTT BARON MD

Orthopaedic Surgery

1,057

$32.9K

464
332 are 65+

13%
patients receiving schedule two controlled substances

Avg: 23%

41%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 10%

$31
Average prescription price

Avg: $40

STEVEN GROFF M.D.

Orthopaedic Surgery

983

$16.9K

435
354 are 65+

7%
patients receiving schedule two controlled substances

Avg: 23%

19%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 10%

$17
Average prescription price

Avg: $40

THOMAS BROCKMEYER MD

Orthopaedic Surgery

868

$19.8K

385
258 are 65+

23%
patients receiving schedule two controlled substances

Avg: 23%

45%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 10%

$23
Average prescription price

Avg: $40

STEPHEN LONGENECKER MD

Orthopaedic Surgery

1,038

$39.2K

371
334 are 65+

7%
patients receiving schedule two controlled substances

Avg: 23%

45%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 10%

$38
Average prescription price

Avg: $40

CHRISTOPHER MCCLELLAN D.O.

Orthopaedic Surgery

1,325

$51.4K

371
287 are 65+

12%
patients receiving schedule two controlled substances

Avg: 23%

61%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 10%

$39
Average prescription price

Avg: $40

ARI PRESSMAN MD

Orthopaedic Surgery

774

$21.1K

359
228 are 65+

9%
patients receiving schedule two controlled substances

Avg: 23%

57%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 10%

$27
Average prescription price

Avg: $40

STEVEN TRIANTAFYLLOU MD

Orthopaedic Surgery

1,425

$29.8K

355
259 are 65+

35%
patients receiving schedule two controlled substances

Avg: 23%

30%
patients receiving schedule three controlled substances

Avg: 36%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 10%

$21
Average prescription price

Avg: $40

THOMAS MUTSCHLER MD

Orthopaedic Surgery

797

$15.6K

353
320 are 65+

16%
patients receiving schedule two controlled substances

Avg: 23%

27%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 10%

$20
Average prescription price

Avg: $40

KIRK PANDELIDIS M.D.

Orthopaedic Surgery

952

$12K

345
268 are 65+

6%
patients receiving schedule two controlled substances

Avg: 23%

11%
patients receiving schedule three controlled substances

Avg: 36%

19%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 10%

$13
Average prescription price

Avg: $40

PAUL POLLICE MD

Orthopaedic Surgery

769

$23.1K

343
312 are 65+

18%
patients receiving schedule two controlled substances

Avg: 23%

13%
patients receiving schedule three controlled substances

Avg: 36%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 10%

$30
Average prescription price

Avg: $40

CARL BECKER MD

Orthopaedic Surgery

849

$27.9K

339
206 are 65+

47%
patients receiving schedule two controlled substances

Avg: 23%

37%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 10%

$33
Average prescription price

Avg: $40

CHRISTOPHER BELLICINI DO

Orthopaedic Surgery

970

$39.1K

338
281 are 65+

46%
patients receiving schedule two controlled substances

Avg: 23%

23%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 10%

$40
Average prescription price

Avg: $40

MICHAEL LEVINE M.D.

Orthopaedic Surgery

897

$30.1K

335
268 are 65+

28%
patients receiving schedule two controlled substances

Avg: 23%

31%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 10%

$34
Average prescription price

Avg: $40

ROBERT LISS M.D.

Orthopaedic Surgery

833

$26.9K

331
279 are 65+

13%
patients receiving schedule two controlled substances

Avg: 23%

30%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 10%

$32
Average prescription price

Avg: $40

RAYMOND DAHL D.O.

Orthopaedic Surgery

1,239

$34.5K

331
216 are 65+

33%
patients receiving schedule two controlled substances

Avg: 23%

44%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 10%

$28
Average prescription price

Avg: $40

EASWARAN BALASUBRAMANIAN MD

Orthopaedic Surgery

1,088

$39.1K

330
195 are 65+

25%
patients receiving schedule two controlled substances

Avg: 23%

17%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 10%

$36
Average prescription price

Avg: $40

GREGORY BISIGNANI MD

Orthopaedic Surgery

798

$42.4K

330
282 are 65+

5%
patients receiving schedule two controlled substances

Avg: 23%

24%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 10%

$53
Average prescription price

Avg: $40

MICHAEL TRANOVICH M.D.

Orthopaedic Surgery

1,071

$34.6K

329
228 are 65+

5%
patients receiving schedule two controlled substances

Avg: 23%

34%
patients receiving schedule three controlled substances

Avg: 36%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 10%

$32
Average prescription price

Avg: $40

TIMOTHY HONKALA M.D.

Orthopaedic Surgery

972

$34.4K

323
275 are 65+

10%
patients receiving schedule two controlled substances

Avg: 23%

46%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 10%

$35
Average prescription price

Avg: $40

STEPHEN HRIBAR M.D.

Orthopaedic Surgery

676

$16.9K

321
267 are 65+

8%
patients receiving schedule two controlled substances

Avg: 23%

43%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 10%

$25
Average prescription price

Avg: $40

BRUCE MENKOWITZ M.D.

Orthopaedic Surgery

1,500

$40.9K

319
245 are 65+

34%
patients receiving schedule two controlled substances

Avg: 23%

42%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 10%

$27
Average prescription price

Avg: $40

MICHAEL MORITZ M.D.

Orthopaedic Surgery

807

$20.1K

317
265 are 65+

27%
patients receiving schedule two controlled substances

Avg: 23%

20%
patients receiving schedule three controlled substances

Avg: 36%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 10%

$25
Average prescription price

Avg: $40

JAMES MACIELAK M. D.

Orthopaedic Surgery

2,077

$63.8K

316
179 are 65+

35%
patients receiving schedule two controlled substances

Avg: 23%

38%
patients receiving schedule three controlled substances

Avg: 36%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 10%

$31
Average prescription price

Avg: $40

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank